Aspen Pharmacare
Boris Charchyan is a seasoned pharmaceutical executive with extensive experience in leadership roles across Russia and the CIS region. Currently serving as Regional CEO and Area General Manager at Aspen Pharma Group since September 2019, Charchyan previously held positions including Business Unit Director for Insulin at Novo Nordisk and Chief Commercial Officer at Biologische Heilmittel Heel GmbH. Additional experience includes General Manager for Russia and neighboring countries at ViiV Healthcare, Regional Director at GSK, and various leadership roles at Astellas Pharma. Charchyan holds an MBA in Marketing and Sales from The Russian Presidential Academy of National Economy and Public Administration and a Master's degree in Economics from the Russian Foreign Trade Academy.
This person is not in any teams
This person is not in any offices
Aspen Pharmacare
10 followers
Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries in Europe, Commonwealth of Independent States (CIS), Latin America, the Middle East and North Africa, Canada, as well as Mauritius-based Aspen Global Incorporated. The South African business provides branded, generic, over-the-counter, consumer health and infant nutritional products, which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa. Its business in Asia Pacific includes operations in Australasia, the Philippines, Taiwan and Japan.